Ondine Biomedical Strengthens Leadership Team with the Appointment of Michael Behlke as non-Board CFO & COO
Ondine Biomedical Strengthens Leadership Team with the Appointment of Michael Behlke as non-Board CFO & COO
The Growth Government
Ondine Biomedical Inc. (LON: OBI), the Canadian life sciences company pioneering light-activated antimicrobial treatments, confirms that King’s College Hospital (KCH) will be running a pilot of its Steriwave® light-activated antimicrobial technology.
London stocks closed the week positively after domestic inflation fell to the Bank of England’s 2% target earlier this week, increasing the likelihood of an interest rate cut in August.
UK Tech Giants This week we were perhaps reminded why there are few UK tech giants, with the acquittal of Autonomy entrepreneur Mike Lynch on fraud charges in the US. Quite
Shares of Ondine Biomedical Inc. saw an increase on Friday afternoon following the announcement that the company will be raising funds to advance the commercialization of its primary antimicrobial treatment.
Currently, a trend among small- and microcap companies involves raising modest amounts of capital by selling shares at significantly reduced prices.